Engflag

Cefaclor ABC

Quick links to important sections

Cefaclor ABC

Cefaclor ABC_EN

Method of action: Bactericidal

Treatment option: Asymptomatic bacteriuria, Bronchitis, Gonorrhea, Influenza, Infection, Infection,Urinary Tract, Middle Ear Infection, Fever, COPD,Acute, Acute Bronchitis

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cefaclor ABC

This foundational section provides a clear, patient-friendly overview of the identity and general nature of the medication Cefaclor ABC.

Quick Facts

Property Description
Active Ingredient Cefaclor
Form Capsule, Tablet (Extended-release available), Oral Suspension
Pharmacological Class Second-Generation Cephalosporin (Antibiotic)
Common Use Treating bacterial infections
Origin Semisynthetic

Defining the Medicine and Its Class

Cefaclor ABC is a prescription antibiotic primarily used to treat infections caused by susceptible bacteria. Its active substance, Cefaclor, is a semisynthetic compound that belongs to the cephalosporin family of antimicrobials. This classification confirms its role as a powerful beta-lactam antibiotic designed to eliminate harmful microorganisms. This mode of action is recognized for its effectiveness against common respiratory and skin infections.

Cefaclor is specifically classified as a second-generation cephalosporin antibiotic. This designation is key because it means Cefaclor typically offers a broader spectrum of activity compared to first-generation drugs, making it a versatile choice in treatment protocols.

General Purpose and Available Forms

The general purpose of Cefaclor ABC is to help the body overcome bacterial infections, such as those affecting the ears or throat. Its mechanism is bactericidal—it works by directly killing the bacterial cells by interfering with their ability to build a protective cell wall. This direct-kill action targets the underlying microbial cause.

Cefaclor ABC is a single-active-ingredient product intended for oral administration (by mouth). It is commonly available in several forms, including capsules, standard tablets, and an oral suspension (liquid form), which is frequently utilized in the pediatric setting. This availability of different forms ensures appropriate administration across various patient groups and age ranges.

Regulatory References

  1. DailyMed Label (NIH)
  2. DailyMed Label (NIH)

What side effects are possible with Cefaclor ABC?

Cefaclor ABC: Possible Side Effects and Safety Information

This section summarizes the officially documented adverse reactions and safety considerations for Cefaclor ABC, a cephalosporin antibiotic, as described in regulatory sources.

Adverse Reactions Overview

Side effects commonly reported in clinical trials and post-marketing surveillance primarily involve gastrointestinal disturbances (such as diarrhea and nausea) and various hypersensitivity reactions. Overall hypersensitivity reactions, including rash and urticaria, are reported in a small percentage of patients. Other reactions involve hematologic changes, such as eosinophilia and a positive Coombs' test, and transient elevations of liver enzymes (AST/ALT).

Serious and Clinically Significant Risks

Certain adverse effects, though less frequent, are considered serious and require immediate medical attention. These include anaphylaxis (a severe allergic reaction), pseudomembranous colitis (severe diarrhea caused by C. difficile overgrowth), and severe skin reactions like Stevens-Johnson Syndrome (SJS). Of particular note is the potential for serum-sickness-like reactions, which are reported more often in children than adults, and typically manifest as skin rash, arthralgia/arthritis, and fever. Seizures have been reported, particularly when the drug is given to patients with existing renal impairment without adequate dose adjustment.

Safety Considerations and Restrictions

Cefaclor ABC is contraindicated in individuals with a known allergy to the cephalosporin class of antibiotics. Caution is warranted in patients with a history of penicillin allergy due to the possibility of cross-sensitivity. The drug must be used with caution in patients with markedly impaired renal function, as dose adjustment is often required to prevent potential toxicity. Prolonged or repeat use may lead to the overgrowth of non-susceptible organisms or superinfection.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents specify the clinical presentation and required emergency actions for an overdose of Cefaclor ABC. Documented manifestations primarily involve the gastrointestinal system, including nausea, vomiting, diarrhea, and epigastric distress. Regulatory labeling notes that the severity of the epigastric distress and diarrhea is typically dose-related.

A severe outcome noted within the cephalosporin class is the potential for seizures. This risk is specifically highlighted for patients with renal impairment where the established dosage reduction guidelines may not have been followed.

Regulatory authorities mandate that immediate medical attention must be sought if an adverse reaction occurs. For life-threatening symptoms, such as collapse, seizure, trouble breathing, or unresponsiveness, it is required to contact a poison control helpline or emergency services immediately.

In the event of an overdose, management is defined as supportive. There is no specific antidote documented in official labeling. For the ingestion of an extremely large quantity—specifically more than five times the normal daily dose—the procedure of gastric lavage may be considered. Procedural measures like hemodialysis, peritoneal dialysis, or forced diuresis are not established as beneficial for management. If seizures occur, the drug should be discontinued, and anticonvulsant therapy may be administered as clinically indicated.

Therapeutic Uses of Cefaclor ABC

What Cefaclor ABC Treats: Main Uses and Benefits

Cefaclor ABC is applicable within clinical settings that involve acute or disruptive symptom patterns, and is relevant in conditions characterized by periods of heightened symptoms. This medication is used in the management of conditions presenting with systemic or localized discomfort, such as pneumonia and other lower respiratory tract (lung) infections. It helps address symptom clusters that may become intense or disruptive, such as sore throat, localized pain, and fever, which are symptoms that create noticeable physiological strain.

It is commonly used when short-term symptomatic assistance is needed, often applied during phases when symptoms become more noticeable. Cefaclor provides supportive relief when symptoms interfere with routine activities, and helps patients cope more steadily with symptom fluctuations. This process assists with maintaining functional stability during symptomatic phases.

Quick Fact: Symptom Management Focus

Symptom Domain Primary Symptom Management Focus
Systemic Symptoms Helps manage fever and malaise
Respiratory Symptoms Assists with easing cough and inflammation
Localized Pain Relevant for managing earache and sore throat
Infectious Signs Applied in addressing redness and swelling

Regulatory References

  1. NIH MedlinePlus overview of Cefaclor

Eligibility and Restrictions for Use

Who Can and Cannot Use Cefaclor ABC?

The official eligibility for Cefaclor ABC is defined by regulatory documents, focusing on patient history and physiological status. Use is approved for adults and pediatric patients aged one month or older.

Contraindications and Restrictions

Classification Rule and Affected Population
Contraindicated Prohibited for patients with a known allergy to cephalosporin antibiotics. Contraindicated for individuals with Porphyria and a documented severe penicillin allergy.
Not Established Safety and effectiveness have not been established for use in infants less than one month of age.
Use with Caution Required for patients with a history of penicillin sensitivity due to cross-hypersensitivity risk. Also required for patients with a history of gastrointestinal disease, particularly colitis.

Condition-Specific Eligibility

The medicine should be administered with caution in the presence of markedly impaired renal function; clinical observation and careful studies are necessary in this limited experience group. In older adults, the dose is generally unchanged if renal function is normal, but the dose must be selected carefully due to common age-related decrease in kidney function. For pregnancy, Cefaclor is categorized as B, meaning it should be used only if clearly needed. For nursing mothers, caution should be exercised as small amounts are detected in breast milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes formally documented interaction patterns for Cefaclor ABC as stated in official government regulatory documents.

Interactions Affecting Drug Exposure

Substance Interaction Mechanism Official Outcome
Probenecid Renal tubular secretion inhibition Increases and prolongs Cefaclor serum concentrations
Antacids (Aluminum/Magnesium) Interference with absorption Diminishes the extent of Cefaclor absorption

Co-administration of Cefaclor ABC with Probenecid officially results in increased drug levels because Probenecid competes for the same renal clearance pathway. This is a pharmacokinetic interaction that reduces Cefaclor clearance. When using aluminum- or magnesium-containing antacids, regulatory documents require a timing separation of at least one hour, as taking them together is documented to reduce the total amount of Cefaclor absorbed.

Interactions Affecting Coagulation

Official reports document a potential interaction with oral anticoagulants, such as Warfarin. This pharmacodynamic interaction may lead to increased prothrombin time, with or without clinical bleeding, and requires careful consideration.

Food and Special Population Notes

While food may delay the rate of absorption of immediate-release Cefaclor, the total amount absorbed remains unchanged. For patients with markedly impaired renal function, the serum half-life of Cefaclor is officially documented to be prolonged, increasing the risk of drug accumulation, which affects the overall interaction profile.

Mechanism of Action

How Cefaclor ABC Works — Mechanism of Action

Cefaclor's core mechanism is the irreversible covalent inhibition of bacterial Penicillin-Binding Proteins (PBPs), which are transpeptidases essential for the final cross-linking step in peptidoglycan synthesis. The drug's beta-lactam structure binds to the active site of these enzymes, preventing them from assembling the rigid structural component of the bacterial cell wall.

This inhibition triggers a lethal mechanistic cascade. The cell wall loses its structural integrity and cannot withstand the internal osmotic pressure, leading to the rapid rupture, or lysis, of the bacterial cell. This process results in a bactericidal effect that causes a systemic reduction in the viable bacterial population. The mechanism's activity is subject to constraint by bacterial defense pathways, specifically the production of beta-lactamase enzymes that chemically cleave and inactivate the drug's essential ring structure before it can engage the PBP targets.

Dosage and Administration Information

How to Use Cefaclor ABC

The administration of Cefaclor ABC follows established protocols detailing the required route, dosing schedule, and specific handling instructions. The medicine is designated solely for oral administration and is available in formulations including capsules, extended-release tablets, and powder for oral suspension.

Standard Dosing and Frequency Patterns

The typical adult regimen for immediate-release forms is 250 mg every 8 hours (q8hr), although the dose may be increased to 500 mg every 8 hours for certain conditions, with a maximum daily dose not to exceed 4 g. Extended-release tablets are generally taken every 12 hours (q12hr) at 375 mg or 500 mg.

The course duration is generally 7 to 10 days, and therapy must be continued for a minimum of 10 days for infections caused by beta-hemolytic streptococci. Treatment should be continued for 48 to 72 hours after signs of infection resolution are observed.

Administration Conditions and Special Instructions

Feature Administrative Guidelines
Food Relationship Immediate-release forms may be taken with or without food. Extended-release tablets must be taken with a meal.
Physical Handling Extended-release tablets must be swallowed whole and must not be crushed, split, or chewed.
Pediatric Use Dosing for children over one month of age is based on weight, typically 20 mg/kg/day in divided doses every 8 hours.
Preparation The oral suspension requires reconstitution with a specified volume of water and must be shaken thoroughly before each measured dose.

These instructions define the standardized protocol for using Cefaclor ABC.

Recent Clinical Evidence

Cefaclor, a second-generation cephalosporin antibiotic, has a long history of clinical use and continues to be studied for its role in treating bacterial infections, primarily those of the respiratory tract, ear, skin, and urinary tract.

Efficacy in Common Infections

Clinical trials have established Cefaclor's efficacy against susceptible strains of common respiratory pathogens, including Streptococcus pneumoniae and Haemophilus influenzae. In studies evaluating otitis media (middle ear infection) in children, Cefaclor showed clinical effectiveness comparable to first-line agents like amoxicillin, particularly in cases involving H. influenzae.

Comparative studies investigating upper respiratory tract infections (such as pharyngitis/tonsillitis caused by Streptococcus pyogenes) found that Cefaclor's clinical effectiveness was statistically similar to penicillin V potassium, meeting non-inferiority endpoints for bacterial eradication.

Formulations and Pharmacokinetics

Research has explored novel formulations of Cefaclor, such as extended-release tablets, to potentially improve patient adherence and pharmacokinetic profiles. Studies comparing immediate-release (IR) and extended-release (ER) versions indicate that the ER formulation retains the established efficacy and tolerability attributes of the IR product, primarily varying in its rate of dissolution. Pharmacokinetic data suggest that Cefaclor is generally well-absorbed, though its absorption may be reduced if taken concurrently with antacids.

Antimicrobial Resistance and Spectrum

Cefaclor demonstrates activity against many bacteria that produce beta-lactamase enzymes, which can inactivate certain penicillins and first-generation cephalosporins. However, its effectiveness is limited against non-susceptible organisms, such as methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas species, and specific strains of extended-spectrum beta-lactamase (ESBL)-producing E. coli. Ongoing surveillance remains crucial for guiding its appropriate use against local patterns of antimicrobial resistance.

Key Studies & References

  1. Cefaclor Capsules USP - DailyMed (Official Prescribing Information)

Frequently Asked Questions (FAQ)

Common questions about Cefaclor ABC (FAQ)

Q: What is Cefaclor ABC used for?

Cefaclor ABC is an antibiotic medication that belongs to a class of drugs called cephalosporins. It is used to treat certain bacterial infections in various parts of the body, including:

  • Respiratory tract infections (e.g., bronchitis, pneumonia)
  • Ear infections (otitis media)
  • Skin and soft tissue infections
  • Urinary tract infections

It works by stopping the growth of bacteria.

Q: How should I take Cefaclor ABC?

Cefaclor ABC is usually taken by mouth as a capsule, tablet, or liquid suspension. The way you take it depends on the specific form prescribed by a healthcare provider.

General guidance for taking Cefaclor ABC includes:

  • Take the medication exactly as prescribed by your doctor.
  • It can usually be taken with or without food. However, follow the specific instructions on your prescription label.
  • Take doses at regularly spaced intervals throughout the day.
  • Do not skip doses or stop taking the medication early, even if you start to feel better. Finishing the entire course helps prevent the infection from returning and reduces the risk of antibiotic resistance.

Q: What should I do if I miss a dose of Cefaclor ABC?

If you miss a dose of Cefaclor ABC, take it as soon as you remember. However, if it is close to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule.

Do not take a double dose to make up for a missed one.

Q: What are the common side effects of Cefaclor ABC?

Like many medications, Cefaclor ABC can cause side effects. Common side effects may include:

  • Gastrointestinal issues, such as diarrhea, nausea, vomiting, or stomach pain.
  • Headache
  • Vaginal yeast infection in women
  • Hives or mild rash

Most of these side effects are typically mild and may resolve as your body adjusts to the medication. If any side effect becomes severe or bothersome, consult your healthcare provider.

Q: Can I drink alcohol while taking Cefaclor ABC?

Moderate alcohol consumption is generally not known to cause significant adverse reactions when taking Cefaclor ABC.

However, it is generally recommended to avoid excessive alcohol intake while you are ill and taking any medication. Always speak with your healthcare provider or pharmacist about specific concerns related to alcohol consumption and your treatment plan.

Q: Can Cefaclor ABC interact with other medications?

Yes, Cefaclor ABC has the potential to interact with other drugs. Some notable interactions include:

  • Anticoagulants (blood thinners), such as warfarin: Cefaclor may increase the effect of these medications, requiring careful monitoring.
  • Probenecid (used for gout): This medication can increase the amount of Cefaclor in the body, potentially increasing its effects.

It is essential to inform your healthcare provider about all prescription, over-the-counter, and herbal supplements you are currently taking before starting Cefaclor ABC. This helps your doctor check for potential drug interactions.

How should Cefaclor ABC be stored and disposed of?

How to Store and Dispose of Cefaclor ABC

Official regulatory information requires specific handling for both the dry product and the mixed suspension.

Storage Requirements

  • Capsules/Tablets (Dry): Store at Controlled Room Temperature (15 C to 30 C), away from excess heat and moisture. Keep in the original tightly closed, light-resistant container.
  • Oral Suspension (Liquid): The reconstituted suspension must be stored in a refrigerator (2 C to 8 C). Do not freeze the liquid.

Stability and Protection

  • In-Use Limit: The refrigerated liquid suspension must be discarded after 14 days of reconstitution.
  • Child Safety: Keep the medication out of sight and reach of children and securely lock safety caps.

Disposal Guidelines

  • Unused or expired Cefaclor must be disposed of according to local pharmaceutical waste regulations. Do not flush the medication down the toilet or place it in household trash to prevent the antibiotic from entering the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagItaly

Equivalent of Cefaclor ABC found in:

A-Z Index: